Alpha-1 Adrenergic Stimulation of Glucose Uptake in Rat White Adipocytes1
- Laboratoire de Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, UMR 5578, CNRS-Faculté de Médecine, Lyon, Cedex 08, France
Abstract
We recently demonstrated that adipocyte lactate production depends onalpha-1 adrenergic control and that adipocytes can produce lactate even when insulin-stimulated glucose uptake is markedly impaired. This prompted us to investigate the glucose uptake in response to an alpha-1 adrenergic stimulation. We measured the adrenergic regulation of glucose uptake by adipocytes isolated from epididymal white adipose tissue using agonists (norepinephrine, phenylephrine and isoproterenol) and antagonists (prazosin and propranolol) of alpha-1 andbeta adrenoceptor subtypes. Our results show that the maximal glucose uptake obtained in the presence of 10−8 M norepinephrine is partially inhibited by prazosin (10−6 M, 57%) or propranolol (10−6 M, 52%) suggesting that glucose uptake is subjected to both alpha-1 and betaregulation. Indeed, our findings show that glucose uptake is dose-dependently increased by phenylephrine. This stimulation is totally inhibited by prazosin (10−6 M). Isoproterenol stimulated glucose uptake. The stimulation of glucose uptake by isoproterenol is totally inhibited in the presence of propranolol (10−6 M) in the incubation medium. Our results demonstrate for the first time that alpha-1 adrenergic subtype is involved in the regulation of glucose uptake by white adipocytes.
Footnotes
-
Send reprint requests to: Alain Géloën, Ph.D., Laboratoire de Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, UMR 5578, CNRS-Faculté de Médecine, Lyon Nord, 8 Avenue Rockefeller, 69373 Lyon, Cedex 08, France.
-
↵1 G.F. was supported by a grant from Ministère de la Recherche et des Techniques. The authors wish to acknowledge financial support from Région Rhône-Alpes.
- Abbreviations:
- KRB buffer
- Krebs-Ringer bicarbonate buffer (25 mM HEPES and 6 mM glucose, pH 7.4
- BSA
- bovine serum albumin
- HEPES
- 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
-
- Received January 6, 1998.
- Accepted April 9, 1998.
- The American Society for Pharmacology and Experimental Therapeutics



